Vaxart Announces Preliminary Results of Annual Meeting of Stockholders
June 13, 2025 16:52 ET | Source: Vaxart, Inc. SOUTH SAN FRANCISCO,…
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 13, 2025 16:01 ET | Source: Nurix Therapeutics, Inc. SAN FRANCISCO,…
RAPT Therapeutics Announces Effective Date for 1-for-8 Reverse Stock Split
June 13, 2025 09:00 ET | Source: RAPT Therapeutics, Inc. SOUTH SAN…
Clearmind Medicine Engages Leading Government and Political Affairs Firm to Advance Psychedelic Therapeutics
Vancouver, Canada, June 12, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Engages Leading…
RadioMedix Debuts Proprietary bench top Pb Generator to Support Targeted Alpha Therapy Development
New bench top ²¹²Pb generator to expand clinical-grade isotope supply for targeted…
MiNK Therapeutics Announces Virtual Annual Shareholders Meeting
June 10, 2025 13:33 ET | Source: MiNK Therapeutics NEW YORK, June…
Keros Therapeutics Announces Participation at Goldman Sachs 46th Annual Global Healthcare Conference
June 06, 2025 16:01 ET | Source: Keros Therapeutics, Inc. LEXINGTON, Mass.,…
RESTEM to Present Phase 2/3 IIMPACT Trial Design in Idiopathic Inflammatory Myopathy at EULAR 2025 Congress
June 06, 2025 16:07 ET | Source: Restem MIAMI, June 06, 2025…
Boundless Bio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
June 05, 2025 16:58 ET | Source: Boundless Bio, Inc. SAN DIEGO,…
ImPact Biotech Announces Treatment of First Patient in Phase 1 Clinical Trial of Padeliporfin VTP in Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma (PDAC)
June 05, 2025 16:31 ET | Source: ImPact Biotech – Previously inoperable…